Side-by-side matrix of up to 4 real pharmacy-benefit-management, formulary, reimbursement & market-access records — the six deterministic scoring engines, covered-lives & performance metrics and formulary, reimbursement, pricing, utilization & specialty matrices, with the best value in each numeric row highlighted.
Scores deterministic, rules-based — not AI. Illustrative data. Organization names are real PBMs / market-access organizations; all capabilities, covered-lives, formulary-influence, regulatory compliance, success rates and performance figures are synthetic demonstration data — verify directly and via vendor qualification before any sourcing decision.
PBM capabilityiHeadline breadth across the three core PBM domains — formulary, reimbursement and utilization management — plus therapeutic-area coverage.
—Not recorded
—Not recorded
Formulary influenceiLeverage over formulary decisions, from covered lives, health-plan partnerships, the formulary-influence score and the breadth of formulary programs.
—Not recorded
—Not recorded
Contracting depthiSophistication of pricing and contracting — manufacturer contracting, rebate administration and value-based / outcomes-based agreements.
—Not recorded
—Not recorded
Specialty managementiStrength in specialty pharmacy — specialty programs, network size, cell-&-gene therapy support and rare-disease programs.
—Not recorded
—Not recorded
Regulatory reachiBreadth of the compliance and market footprint, from regulatory frameworks, coverage types and geographic coverage.
—Not recorded
—Not recorded
Performance & qualityiIllustrative operating performance — market-access, reimbursement and SLA success rates, with few audit findings.
—Not recorded
—Not recorded
Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Formulary-influence scoreiSelf-reported 0–100 measure of how strongly the organization can shape formulary placement decisions.
—
—
Market-access success rateiSelf-reported share of market-access engagements that achieved the intended coverage or reimbursement outcome.
—
—
Reimbursement success rateiSelf-reported share of reimbursement or claims submissions that were approved.
—
—
SLA compliance rateiSelf-reported share of service-level agreement commitments the organization met on time.
—
—
Open CAPAsiNumber of currently open corrective-and-preventive-action items — fewer is better.
—
—
Audit findings (yr)iNumber of audit findings recorded in the last year — fewer is better.
—
—
Synthetic + historically-framed capability flags · not a vendor-qualification determination — verify directly and via vendor qualification before any sourcing decision. Covered-lives, influence and success-rate figures are self-reported illustrative metrics, not audited platform data.
ComparingCVSESI
Best in row · deterministic, rules-based — not AI · illustrative seed data
has it recorded as not offered not recorded — nobody has published it either way